DalsnaFinance

Catalyst Pharmaceuticals (CPRX) Q1 2026 Earnings: EPS Beat of 7.5% Driven by Strong Profitability - Margin Guidance

Stocks newsline.com By newsline.com 13 Jun 2026 16:44 1 min read
Catalyst Pharmaceuticals (CPRX) Q1 2026 Earnings: EPS Beat of 7.5% Driven by Strong Profitability - Margin Guidance

Catalyst Pharmaceuticals (CPRX) Q1 2026 Earnings: EPS Beat of 7.5% Driven by Strong Profitability - Margin Guidance  newsline.com

Catalyst Pharmaceuticals (CPRX) Q1 2026 Earnings: EPS Beat of 7.5% Driven by Strong Profitability - Margin Guidance newsline.com

Read the full story on newsline.com → Opens the original article on news.google.com

Summary aggregated from newsline.com's public RSS feed. The full reporting belongs to newsline.com — please read it on their site.